Monitoring of the *healthy* immune response in the sentinel lymph node of patients undergoing a prophylactic mastectomy.
Recruiting
- Conditions
- Breastcancer10006291mammacarcinoma
- Registration Number
- NL-OMON36250
- Lead Sponsor
- Antoni van Leeuwenhoek Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Women
Age 18 yrs or older
Undergoing prophylactic mastectomy
Written informed consent
Exclusion Criteria
1. Presence of invasive breast cancer or ductal carcinoma in situ upon pathological examination
2. Contralateral breastcancer
3. Any other form of cancer
4. Any surgery or (needle) biopsy of the breast or axilla in the last 3 months
5. Current immunosuppressive therapy (including chemotherapy)
6. Current immunotherapy
7. Autoimmune disorders
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Establishing the *healthy* immune response in SLN of patients undergoing a<br /><br>prophylactic mastectomy.</p><br>
- Secondary Outcome Measures
Name Time Method <p>NA</p><br>